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Abstract
Background: Recent genome-wide association (GWA) studies have identified a number of novel genetic determinants of
blood lipid concentrations in Europeans. However, it is still unclear whether these loci identified in the Caucasian GWA
studies also exert the same effect on lipid concentrations in the Chinese population.
Methods and Results: We conducted a replication study assessing associations between SNPs at 15 loci and blood lipid and
lipoprotein concentrations in two Chinese cohorts, comprising 2533 and 2105 individuals respectively. SNPs in APO(A1/C3/
A4/A5), TIMD4-HAVCR1, DOCK7, TRIB1, ABCA1, and TOMM40-APOE showed strong associations with at least one lipids trait,
and rs174546 in FADS1/2/3 showed modest association with triglyceride in the Chinese population.
Conclusions: We successfully replicated 7 loci associated plasma lipid concentrations in the Chinese population. Our study
confirmed the implication of APO(A1/C3/A4/A5), TOMM40-APOE, ABCA1, DOCK7, TIMD4-HAVCR1, TRIB1 and FADS1/2 in
plasma lipid and lipoprotein concentrations in Chinese population.
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Introduction
Plasma lipids and lipoproteins concentrations are important
risk factors for atherosclerosis and related vascular diseases
[1]. Twin and family studies suggest that about 50% of the
variation in plasma lipid and lipoprotein levels is genetically
determined [2].
A search for the genetic contributions to variation in plasma
lipid and lipoprotein levels has been ongoing for several decades
[3]. Since 2007, genome-wide association (GWA) studies have
obtained great success and have implicated common variants in
numerous loci and genes as being the genetic influences
underlying lipid and lipoprotein levels [4,5,6,7,8,
9,10,11]. Kathiresan’s group [12] recently performed a compre-
hensive meta-analysis of the GWA studies and identified 95
loci significantly associated with blood lipids. These associa-
tions were primarily found in European ancestry. Following
studies successfully replicated most of these loci in East Asian
population [12,13,14,15,16,17]. However, some of the loci
showed no significant association with lipid and lipoprotein levels
in Asian population, including the MAFB, NCAN/CLIP2/PBX4
and MVK/MMAB loci [12,14,17]. It is therefore important to
confirm whether known loci have consistent effects across ethnic
groups.
The purpose of this study was to replicate the previously
reported genetic loci in the Chinese population. We firstly
evaluated association between lipid levels and 15 loci selected
from the three recent GWAS reports [4,7,9] in Cohort1,
comprising 2, 533 Chinese individuals, and selected 10 out of
the 15 loci on the basis of the strength of statistical evidence. We
then tested association of the 10 loci with lipid traits in Cohort2,
comprising 2,105 individuals, to confirm the findings in Cohort1.
Finally, we combined the two cohorts results together, since both
the two cohort were from Shanghai, with similar genetic
background.
Clinically, the most important plasma lipids and lipoproteins are
triglycerides (TG), total cholesterol (TC), high density lipoprotein
(HDL) cholesterol and low density lipoprotein (LDL) cholesterol.
Several studies have suggested that the lipid ratio (TC/HDL-C)
has greater independent predictive value for coronary heart
disease (CHD) and cardiovascular events than either total
cholesterol or LDL cholesterol levels [3,18]. We therefore focused
on five lipid traits: TG, TC, HDL cholesterol, LDL cholesterol
and the TC/HDL ratio in this study.
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Ethics Statement
The ethics committee of the Shanghai Institute for Biological
Sciences approved this study. Written consents were given by the
patients.
Participants
Participants in the present study comprised two groups,
Cohort1 and Cohort2. Cohort1 was primarily designed for a
case-control study of type 2 diabetes (including 1,360 non-type 2
diabetes controls and 1,173 type 2 diabetes patients). Cohort2 was
a community-based prospective epidemiologic cohort of 2,105
subjects. Individuals known to be on lipid-lowering therapy were
excluded. Both cohorts were recruited from Shanghai, China. The
characteristics of participants are summarized in Table 1.
For all individuals, height, weight, hip and waist circumference
and blood pressure were measured by trained medical profession-
als using a standardized protocol. Body mass index (BMI) was
calculated as weight (kg)/[height (m)]
2. Blood samples were
collected after an overnight fast. Total cholesterol, HDL
cholesterol, LDL cholesterol, triglycerides, and fasting plasma
glucose (FPG) were measured enzymatically according to standard
methods on the Roche modular P800 autoanalyzer (Roche,
Mannheim, Germany) with the appropriate reagents (Roche
Diagnostics CmbH, Mannheim, Germany).
Selection of candidate variants
We selected 15 out of 55 single nucleotide polymorphisms
(SNPs) that achieved genome-wide statistical significance in three
recently published GWA studies [4,7,9]. Three criteria were
adopted to choose SNPs:
1. Only one lead SNP was selected for each locus. For instance,
three GWAS reported seven SNPs in the FADS1/2/3 cluster,
including rs174570, [4] rs174537, rs102275, rs174556, rs1535,
rs174546, [9] and rs174547 [7]. Considering all were in a
region with extremely high degree of linkage disequilibrium
(D’=1.0, r
2=1.0, The International HapMap Project), we
selected one variant, rs174546, to represent this region.
2. We selected only those SNPs with a minor allele frequency
higher than 5% in Chinese population to ensure that this study
had enough statistical power.
3. Loci had been studied in Chinese population [13] were
excluded.
Genotyping
High-molecular-weight genomic DNA was prepared from
venous blood using the QuickGene 610 L Automatic DNA/
RNA Extraction System (Fijifilm, Tokyo, Japan). All genotyping
experiments were done using TaqMan technology on an
ABI7900 system (Applied Biosystems, Foster City, California).
The standard 5 ml polymerase chain reaction (PCR) reactions
were carried out using TaqMan Universal PCR Master Mix
reagent kits under the guidelines provided. Genotype data were
obtained in 97.5% of the DNA samples. Replicate quality control
samples (5% samples) were included and genotyped with 100%
concordance.
Statistical analyses
SHEsis [19] was used to perform the Hardy-Weinberg
Equilibrium (HWE) test. We assumed an additive model of
inheritance, and conducted multiple linear regressions to assess the
effect of the number of the specified allele of each SNP on five
traits—concentrations of TC, TG, LDL cholesterol, HDL
cholesterol and the TC/HDL ratio. Age, gender, body mass
index (BMI), and type 2 diabetes status were included in the
multiple linear regression models as covariant. Plasma TG and
TC/HDL-C were logarithmically transformed before linear
regression due to skewed distributions. We did not exclude the
type 2 diabetes subjects, in line with previous genome-wide studies
[6,10]. Considering the potential correlation between diabetes and
lipid levels, we included the diabetes status in the association
model as a covariant. Multiple testing corrections were performed
in stage 2 and combined analysis, P,0.001 was considered as
significant, given there were 10 SNPs and 5 traits analyzed.
Results
Stage 1 replication
15 SNPs in 15 loci were genotyped in Cohort 1 comprising 2533
individuals at stage 1. Genotype distribution of each SNP did not
deviate from Hardy-Weinberg equilibrium at the 5% level. Results
of the multiple linear regression analysis adjusted for age, gender,
BMI, and type 2 diabetes status are shown in Table 2.
Of the 15 SNPs tested, 8 SNPs including rs10889353 in DOCK7,
rs1501908 in TIMD4-HAVCR1, rs2954029 in TRIB1, rs1883025
in ABCA1, rs964184 in APO(A1/C3/A4/A5), rs2338104 in
MMAB-MVK, rs2650000 in HNF1A, and rs157580 in TOMM40-
APOE, showed significant association (P,0.05) with at least one
lipid level trait.
However, 7 other loci including rs10903129 located in
TMEM57, rs12670798 in DNAH11, rs4936883 in LIPG,
rs2304130 in NCAN, rs7120118 in NR1H3, rs6102059 in MAFB,
and rs174546 in FADS1/2, which had previously been reported to
be associated with plasma lipid levels in European ancestry, did
not show evidence for association with any of the five lipid traits in
the our Chinese sample. Given that the FADS1/2/3 cluster was
reported to be associated with lipid concentrations in all of the
three GWAS papers, we included this locus in the stage 2
replication. Rs6102059 in MAFB showed a relatively low P value
with TC (P,0.09), therefore was also included.
Table 1. Participant characteristics.
Variable Cohort1 Cohort2
n=2533 n=2105
Female gender (%) 65.3 68.7
Age(years) 61695 9 610
Height(cm) 159.567.7 160.968.0
BMI(kg/m
2) 25.063.4 24.763.3
TC(mmol/l) 4.9760.95 4.5360.91
TG(mmol/l) 1.30(0.94,1.86) 1.41(1.01,2.06)
HDL-C(mmol/l) 1.1960.30 1.2460.31
LDL-C(mmol/l) 3.0260.79 2.8460.75
TC/HDL-C 4.26(3.51,5.04) 3.70(3.09,4.48)
Individuals with T2D (%) 1173(46.3) 197(9.4)
Data are shown as mean6standard deviation, or median (25% quantile,75%
quantile).
T2D, type 2 diabetes.
doi:10.1371/journal.pone.0027305.t001
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The 10 selected SNPs were subsequently genotyped in Cohort2,
and 4 of them showed significant association with lipid traits after
multiple testing correction (P,0.001), including variants in TIMD4-
HAVCR1, TRIB1, ABCA1 and APO(A1/C3/A4/A5) (Table 3).
Combined analysis
Considering the two cohorts were from the same place, we
combined the two cohorts together to enhance the statistic
power (Table 4). We found three variants, including rs10889353
in DOCK7 (Combined P,6.5610
24), rs2954029 in TRIB1
(Combined P,5.8610
26) and rs1883025 in ABCA1 (Combined
P,4.0610
24), associated with total cholesterol concentration.
Three variants, including rs10889353 in DOCK7 (Combined
P,5.9610
24), rs2954029 in TRIB1 (Combined P,2.3610
27)
and rs964184 in APO(A1/C3/A4/A5) (Combined P,2.8610
228),
showed significant associationwithtriglyceride concentrations. Two
variants including rs1883025 in ABCA1 (Combined P,2.0610
25)
and rs964184 in APO(A1/C3/A4/A5) (Combined P,3.0610
211),
showed association with HDL cholesterol concentrations. Three
variants including rs2954029 in TRIB1 (Combined P,7.1610
24),
rs964184 in APO(A1/C3/A4/A5) (Combined P,4.6610
26)a n d
rs157580 in TOMM40-APOE (Combined P,2.0610
28) showed
significant association with LDL cholesterol concentrations. Three
variants including rs1501908 in TIMD4-HAVCR1 (Combined
P,1.9610
25), rs2954029 in TRIB1 (Combined P,6.0610
26)
and rs964184 in APO(A1/C3/A4/A5) (Combined P,2.5610
29)
showed association with the ratio of total cholesterol to HDL
cholesterol.
We found marginal association between rs174546 in the
FADS1/2/3 and triglycerides (Combined P,0.01) (Table 4). We
found no significant association between rs2338104 in MMAN-
MVK, rs2650000 in HNF1A or rs6102059 in MAFB and plasma
lipid levels either in Cohort2 or in the combined Cohorts.
Discussion
In this study, we investigated whether the results of three
independent genome-wide European association studies on plasma
lipid and lipoprotein levels were replicatable in the Chinese
population. Of the 15 loci selected from the European GWAS
reports, 7 loci were successfully replicated.
The most significant association was found between rs964184 in
the APO(A1/C3/A4/A5) cluster and triglycerides (Combined
P,2.8610
228). This variant was also found to be associated with
HDL cholesterol, LDL cholesterol, and TC/HDL. Differences in
the G allele frequency (0.22 vs. 0.14) and effects on TG (0.14 vs.
0.30) [7] were found between Chinese and Europeans, suggesting
a higher risk allele frequency and weaker effect in Chinese
population. The APO(A1/C3/A4/A5) cluster encodes important
regulators of fasting lipids, and there is considerable evidence
suggesting that variants in this region are associated with altered
lipid metabolism [20,21]. Fine mapping in this region may help us
to find the functional variant.
Another similar case is rs157580 in TOMM4-APOE, which
encodes Apolipoprotein E, a main apoprotein of the chylomicron,
essential for the normal catabolism of triglyceride-rich lipoprotein
constituents. We found the A allele of rs157580 was associated
with decreased LDL, TC and increased TG in Chinese, which was
different from European population (A allele was associated with
increased LDL, TC and TG) (Table 4 and Table S1) [4]. Two
other SNPs rs4420638 and rs439401 in this region were reported
to be associated with blood lipid profile in both Europeans and
Chinese [4,12,13], and rs439401 (not included in this study) also
showed different effect direction on LDL and TC between the two
ethnic groups. Given the different allele frequencies (A allele of
rs157580, 0.44 vs. 0.67) and different linkage equilibrium patterns
of this region (Figure 1) between Chinese and Europeans, these
discordant results across ethnic groups could be explained by
different linkage patterns between the causal variants and the
tag SNPs that were studied. Nevertheless, these results confirmed
the involvement of variants of this gene cluster in the lipid
metabolism.
We found variant in ABCA1 associated with TC, TG and HDL.
The association with TG was newly identified and retained significant
after adjusting by other lipid traits (data not shown), suggesting variant
in ABCA1 gene played a wider effect on blood lipid profile in the
Chinese population. Recently, Acuna-Alonzo et al [22] reported a
functional ABCA1 gene variant exclusive to Native American and
descent populations is associated with low HDL cholesterol levels and
shows evidence of positive selection. These findings suggest the
importance of ABCA1 genetic variants in lipid metabolism.
We also found variant in DOCK7 associated with TC and TG,
variant in TIMD4-HAVCR1 associated with TC, TG, LDL and
TC/HDL, variant in TRIB1 associated with TC, TG, LDL, and
TC/HDL, with similar effects and same effect directions on blood
lipid traits as previous studies in Europeans [4,7,9,12]. Our study
confirmed that these loci are implicated in lipid metabolism in the
Chinese as well as the European populations.
The FADS1/2/3 cluster locates on 11q12 encoding fatty acid
desaturases, which convert polyunsaturated fatty acids into cell
signaling metabolites and are functionally involved in lipid
metabolism. Previous European studies found variants in the
FADS1/2/3 cluster to be associated with plasma concentrations of
TG, TC, HDL cholesterol and LDL cholesterol [4,7,9,12]. We
found rs174546 in this locus marginally associated with TG
(P,0.01) in Chinese population, with same effect direction to that
in Europeans. This result is consistent with another East Asian
study, which reported a SNP in FADS1/2 is associated with TG in
Japanese and associated with LDL in Mongolian. The linkage
disequilibrium patterns of this region in the Chinese population
somewhat differ with Europeans. For instance, the LD value
between rs174546 and rs174570 is much higher in Chinese
(D’=1.0, r
2=1.0, HapMap, CHB) than in Europeans (D’=1.0,
r
2=0.32, HapMap, CEU). The different linkage disequilibrium
pattern may therefore explain different association profile across
the two ethnic groups.
Rs2338104 in MMAB-MVK was reported to be associated with
HDL cholesterol in studies by Willer [11] and Kathiresan [7], but
in our study this variant showed no association with HDL
cholesterol, which is consistent with a large scale Japanese study
[14]. Similarly, variants in NR1H3, LIPG, DNAH11, HNF1A and
MAFB didn’t show significant association with blood lipid traits in
our study. It is not necessarily the case that these loci do not
influence lipid phenotypes in Chinese. One possible reason is that
because of the modest effect sizes of the individual genetic variants
on lipid traits our sample size is not enough to detect the
association. Another possible reason is the different linkage
disequilibrium pattern in Europeans and East Asian population.
It is possible that these genes may influence lipid levels through
other polymorphisms in East Asian populations. Fine mapping
these regions by deep sequencing or additional screening of dense
arrays would be needed to reveal association between these genes
and lipid levels in the Chinese population.
In conclusion, we successfully replicated association between 7
loci and plasma lipid concentrations in the Chinese population.
Our study confirmed the implication of APO(A1/C3/A4/A5),
TOMM40-APOE, ABCA1, DOCK7, TIMD4-HAVCR1, TRIB1 and
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